Musculoskeletal ultrasound including definitions for ultrasonographic pathology.

…, AK Brown, KP Machold, PG Conaghan - The Journal of …, 2005 - jrheum.org
Ultrasound (US) has great potential as an outcome in rheumatoid arthritis trials for detecting
bone erosions, synovitis, tendon disease, and enthesopathy. It has a number of distinct …

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis

…, P Christensen, PG Conaghan… - Annals of the …, 2013 - ard.bmj.com
The objective was to develop evidence -based recommendations and a research and educational
agenda for the non-pharmacological management of hip and knee osteoarthritis (OA). …

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled …

…, D Van der Heijde, R Landewé, PG Conaghan… - The Lancet, 2015 - thelancet.com
Background Interleukin 17A is a proinflammatory cytokine that is implicated in the pathogenesis
of psoriatic arthritis. We assessed the efficacy and safety of subcutaneous secukinumab, …

The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography

RJ Wakefield, WW Gibbon, PG Conaghan… - Arthritis & …, 2000 - Wiley Online Library
Objective The ability to make an early, accurate diagnosis of rheumatoid arthritis (RA) has
become increasingly important with the availability of new, expensive, and targeted therapies. …

OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring …

M Østergaard, C Peterfy, P Conaghan… - The Journal of …, 2003 - jrheum.org
This article describes the 2002 OMERACT rheumatoid arthritis magnetic resonance image
scoring system (RAMRIS) for evaluation of inflammatory and destructive changes in RA …

Very early treatment with infliximab in addition to methotrexate in early, poor‐prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of …

MA Quinn, PG Conaghan, PJ O'Connor… - … : Official Journal of …, 2005 - Wiley Online Library
Objective Anti–tumor necrosis factor α agents are among the most effective therapies for
rheumatoid arthritis (RA). However, their optimal use is yet to be determined. This 12‐month …

[HTML][HTML] Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score)

…, A Guermazi, GH Lo, AJ Grainger, PG Conaghan… - Osteoarthritis and …, 2011 - Elsevier
OBJECTIVE: In an effort to evolve semi-quantitative scoring methods based upon limitations
identified in existing tools, integrating expert readers’ experience with all available scoring …

EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis

…, S Sokolovic, I Watt, PG Conaghan - Annals of the …, 2013 - ard.bmj.com
Objective To develop evidence-based recommendations on the use of imaging of the joints
in the clinical management of rheumatoid arthritis (RA). Methods The task force comprised …

[HTML][HTML] Synovitis in osteoarthritis: current understanding with therapeutic implications

A Mathiessen, PG Conaghan - Arthritis research & therapy, 2017 - Springer
Modern concepts of osteoarthritis (OA) have been forever changed by modern imaging
phenotypes demonstrating complex and multi-tissue pathologies involving cartilage, …

[HTML][HTML] Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0

…, L Gossec, MA d'Agostino, PG Conaghan… - Journal of clinical …, 2014 - Elsevier
Background Lack of standardization of outcome measures limits the usefulness of clinical
trial evidence to inform health care decisions. This can be addressed by agreeing on a …